MedTrace Logo

Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.

NCT04542512 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2021-03-26

No results posted yet for this study

Summary

Gangrenous cholecystitis is the most common complication of acute cholecystitis.

Preliminary data showed that COVID-19 patients have a high risk to present necrotic cholecystitis.

The Cholecystitis under COVID-19 pandemic WSES (ChoCO-W) study aims to investigate risk factors and high-risk patients to develop necrotic cholecystitis during this pandemic and their management.

Conditions

  • Cholecystitis, Acute
  • Cholecystitis; Gangrenous
  • Cholecystitis Suppurative
  • Covid19

Sponsors & Collaborators

  • World Society of Emergency Surgery

    collaborator OTHER

  • Intercontinental society of Natural Orifice, Endoscopic, and Laparoscopic Surgery

    collaborator UNKNOWN

  • Poissy-Saint Germain Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2021-09-30
Completion
2021-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04542512 on ClinicalTrials.gov